Response evaluation using RECIST and CHOI criteria in patients with well-differentiated pancreatic neuroendocrine tumors (pNET) treated with sunitinib or everolimus

Olivia Hentic, Chantal Dreyer, Magaly Zappa, Pascal Hammel, Cristian Mateescu, Mohamed Bouattour, Sandrine J. Faivre, Philippe Ruszniewski, Eric Raymond
  • Pancreatology, November 2012, Elsevier
  • DOI: 10.1016/j.pan.2012.11.051
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Mohamed Bouattour